KK Stock Shutterstock Our data indicates that Gen X (born between 1965 and 1980) comprises the largest age generation of semaglutide patients, with around 44% of all patients in 2024 being from Gen X
300g per pack | Rich in protein and vitamins | Perfect for vegetarian cooking
FDA approved in April 2025)
Our options include semaglutide and tirzepatide injectable medications that help regulate hunger signals, stabilize blood sugar, and reduce food intake
If youd like a complete overview of how these medications work, visit our GLP-1 Weight Loss: Complete Guide
The trials tell us that, under research conditions, GLP-1s can help people lose roughly 10 to 20 percent of body weight, improve blood sugar, blood pressure, and some lipid markers, and maintain benefits while the drug is continued